Thiazolinone 2-substituted quinolines

Details for Australian Patent Application No. 2005284294 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Michoud, Christophe; Chen, Shaoqing; Chen, Li

Agent Davies Collison Cave

Pub. Number AU-A-2005284294

PCT Pub. Number WO2006/029863

Priority 60/610,767 17.09.04 US

Filing date 15 September 2005

Wipo publication date 23 March 2006

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029863 Priority application(s): WO2006/029863

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005284304-A syringe

2005284293-Substituted hydantoins for the treatment of cancer